Open-Label, Randomized, Single-Dose, 2-Way Crossover Bioequivalence Study Comparing A New Alprazolam Sublingual Tablet Formulation To An Alprazolam Sublingual Tablet.
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 22 Apr 2011
At a glance
- Drugs Alprazolam (Primary)
- Indications Generalised anxiety disorder; Panic disorder
- Focus Pharmacokinetics
- 07 Apr 2011 Status changed from not yet recruiting to withdrawn prior to recruitment, according to ClinicalTrials.gov.
- 09 Mar 2011 Planned end date changed from 1 May 2011 to 1 Jun 2011 as reported by ClinicalTrials.gov.
- 09 Mar 2011 Planned initiation date changed from 1 Mar 2011 to 1 Apr 2011 as reported by ClinicalTrials.gov.